This risk may be caused by the potential presence of N-nitrosodimethylamine (NDMA) contamination in the medicinal product, which may affect human health and life. Potential effects: possible carcinogenic effect, liver damage, other toxic complications.
Download the app and stay informed
Get instant notifications about recalled products and protect your family.
Important Information
Do not use Ranigast (Ranitidine) 0.5 mg/ml solution for infusion, check your medicine, and if in doubt consult a doctor or pharmacist to choose an alternative treatment.
All batches of Ranigast (Ranitidine) 0.5 mg/ml solution for infusion were suspended from the market nationwide and the decision was given immediate enforceability, obliging the marketing authorisation...
If you feel unwell after consuming this product, contact your doctor or call the poison control center.
FAQ
Related